Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
31 May 2019 | Story Eugene Seegers | Photo Barend Nagel
KovsieApp Landing Page
The new KovsieApp’s landing page.

The new KovsieApp will be available from 31 May 2019. This mobile app will be compatible with both iPhone and Android devices and will enable users to access information from the UFS website on their mobile phones at no cost while connected to the on-campus Wi-Fi network.

The first roll-out of the KovsieApp will be primarily aimed at students, who will be able to access their personal information, such as study records, marks, class and exam timetables, mini fee statement, etc. However, for security reasons and privacy requirements, the student will have to register on the app before such information is made available. Later iterations will have additional functionality for staff, for whom space has already been allocated in the app.

Positive Response

During the beta testing phase, a number of students were included in the focus group. Their feedback highlights the value of the app for Kovsie students.

“The app is very smooth and easy to use. Compared to other apps, it has so much more useful information that a student needs, such as checking Gradebook or your financial statement wherever you are. One of the key aspects is that it is data-friendly, even when on mobile data,” said Omar-Raphael Tabengwa, SRC: International Student Council, in his response.

Katleho Lechoo, SRC for Sport on the Bloemfontein Campus, said: “This app is something the students have been looking for, and it brings the university to your pocket. It is convenient to use, especially for those who have to access their academics while travelling for sport. We can’t wait for it to hit the ground running very fast.”

Nomathemba Pakade, Deputy President of the South Campus SRC, had this to say: “For me, this app means convenience and it is going to save me a lot of time, because I can access almost everything on my phone. We couldn't have asked for anything better at this moment.”

Lastly, Mvuyo Madlala, SRC Secretary for the South Campus, said, “The KovsieApp is very efficient and includes all the essential information that a student might require.”

Data accuracy a must

Since students will log in with an OTP sent to the cellphone number linked to their profile, the accuracy of a student’s data will be critical to the correct functioning of the KovsieApp, especially when it comes to personalised information such as timetables and marks. Therefore, students are encouraged to update their contact details and other information, using the Student Self-service page on KovsieLife. Alternatively, you can visit Student Academic Services for assistance (remember to take along your ID or passport as identification). Any errors in a student’s data can cause the KovsieApp to function unpredictably, with the result that the person will be restricted to a public view with limited access to basic personal information.

The future is here!

Get ready to experience the next generation of information access: Download your KovsieApp today!

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept